CD274 and neoplasm: Intriguingly, blocking LAG3, TIM3, or TIGIT alone had a minimal impact on tumor growth inhibition, but was active only in combination with anti-PD-L1/PD-1 treatment, suggesting that the suppressive capacity of the PD-1/PD-L1 axis is dominant over other known co-inhibitory receptors.